104 related articles for article (PubMed ID: 7586778)
1. Correlation between methotrexate pharmacokinetic parameters, and clinical and biological status in rheumatoid arthritis patients.
Bologna C; Anaya JM; Bressolle F; Jorgensen C; Alric R; Sany J
Clin Exp Rheumatol; 1995; 13(4):465-70. PubMed ID: 7586778
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, parallel, single-site pilot trial to compare two different starting doses of methotrexate in methotrexate-naïve adult patients with rheumatoid arthritis.
Hobl EL; Mader RM; Jilma B; Duhm B; Mustak M; Bröll H; Högger P; Erlacher L
Clin Ther; 2012 May; 34(5):1195-203. PubMed ID: 22516039
[TBL] [Abstract][Full Text] [Related]
3. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
[TBL] [Abstract][Full Text] [Related]
4. Association of methotrexate and corticosteroids in the treatment of patients with rheumatoid arthritis.
Bologna C; Jorgensen C; Sany J
Clin Exp Rheumatol; 1996; 14(4):401-6. PubMed ID: 8871839
[TBL] [Abstract][Full Text] [Related]
5. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
6. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
[TBL] [Abstract][Full Text] [Related]
7. Monitoring methotrexate therapy in patients with rheumatoid arthritis.
Wiela-Hojenska A; Orzechowska-Juzwenko K; Swierkot J; Wiland P; Hurkacz M; Szechinski J
Int J Clin Pharmacol Ther; 2004 Aug; 42(8):434-41. PubMed ID: 15366323
[TBL] [Abstract][Full Text] [Related]
8. Evidence of radiographic benefit of treatment with infliximab plus methotrexate in rheumatoid arthritis patients who had no clinical improvement: a detailed subanalysis of data from the anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study.
Smolen JS; Han C; Bala M; Maini RN; Kalden JR; van der Heijde D; Breedveld FC; Furst DE; Lipsky PE;
Arthritis Rheum; 2005 Apr; 52(4):1020-30. PubMed ID: 15818697
[TBL] [Abstract][Full Text] [Related]
9. The influence of methotrexate on the gene expression of the pro-inflammatory cytokine IL-12A in the therapy of rheumatoid arthritis.
Hobl EL; Mader RM; Erlacher L; Duhm B; Mustak M; Bröll H; Högger P; Kalipciyan M; Jilma B
Clin Exp Rheumatol; 2011; 29(6):963-9. PubMed ID: 22133036
[TBL] [Abstract][Full Text] [Related]
10. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
[TBL] [Abstract][Full Text] [Related]
11. Infliximab is associated with improvement in arterial stiffness in patients with early rheumatoid arthritis -- a randomized trial.
Tam LS; Shang Q; Li EK; Wang S; Li RJ; Lee KL; Leung YY; Ying KY; Yim CW; Kun EW; Leung MH; Li M; Li TK; Zhu TY; Chui RK; Tseung L; Yu SL; Kuan WP; Yu CM
J Rheumatol; 2012 Dec; 39(12):2267-75. PubMed ID: 22984272
[TBL] [Abstract][Full Text] [Related]
12. Effect of low dose methotrexate on markers of bone metabolism in patients with rheumatoid arthritis.
El Miedany YM; Abubakr IH; El Baddini M
J Rheumatol; 1998 Nov; 25(11):2083-7. PubMed ID: 9818648
[TBL] [Abstract][Full Text] [Related]
13. Cyclosporine A in the treatment of early rheumatoid arthritis. A prospective, randomized 24-month study.
Drosos AA; Voulgari PV; Papadopoulos IA; Politi EN; Georgiou PE; Zikou AK
Clin Exp Rheumatol; 1998; 16(6):695-701. PubMed ID: 9844762
[TBL] [Abstract][Full Text] [Related]
14. Dietary caffeine intake does not affect methotrexate efficacy in patients with rheumatoid arthritis.
Benito-Garcia E; Heller JE; Chibnik LB; Maher NE; Matthews HM; Bilics JA; Weinblatt ME; Shadick NA
J Rheumatol; 2006 Jul; 33(7):1275-81. PubMed ID: 16821266
[TBL] [Abstract][Full Text] [Related]
15. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
[TBL] [Abstract][Full Text] [Related]
16. Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response.
Haagsma CJ; Russel FG; Vree TB; Van Riel PL; Van de Putte LB
Br J Clin Pharmacol; 1996 Aug; 42(2):195-200. PubMed ID: 8864317
[TBL] [Abstract][Full Text] [Related]
17. Is there an optimal time to administer methotrexate in the treatment of rheumatoid arthritis?
Carpentier N; Bertin P; Marquet P; Sabot C; Bonnet C; Debord J; Lachâtre G; Trèves R
J Rheumatol; 1998 Jul; 25(7):1270-5. PubMed ID: 9676755
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients.
Katayama K; Matsuno T
Mod Rheumatol; 2009; 19(5):513-21. PubMed ID: 19603251
[TBL] [Abstract][Full Text] [Related]
19. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Substantial Liver Fibrosis by Real-time Shear Wave Elastography in Methotrexate-Treated Patients With Rheumatoid Arthritis.
Kim TY; Kim JY; Sohn JH; Lee HS; Bang SY; Kim Y; Kim MY; Jeong WK
J Ultrasound Med; 2015 Sep; 34(9):1621-30. PubMed ID: 26269292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]